Here are some upcoming Pharma events you and your colleagues might be interested in attending:
NOW FREE to Attend for Drug Developers, Researchers, and Academics!
Biomarkers for Rare Non-Oncological Diseases Summit
November 10-11, 2020
The Biomarkers for Rare Non-Oncological Diseases Summit will unite biopharma, diagnostic and healthcare teams to advance the application of precision medicine in rare diseases beyond oncology. Connect with us at BM&Dx 2020 by visiting our virtual booth, or email us to schedule a meeting with our leadership team.
| EMAIL US HERE |
Orphan Drug & Rare Disease Global Congress
November 18-19, 2020
The two-day Congress will provide an interactive, cutting edge and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Attendees will collaborate on practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases.
Genomenon co-founder & Chief Science Officer, Dr. Mark Kiel is speaking at this event on, ‘Big Data for Rare Disease: Comprehensive Genomic Landscapes to Accelerate Drug Development’. Connect with our leadership team by emailing us to schedule a meeting.. Connect with our leadership team by emailing us to schedule a meeting.
FEATURED SPEAKER
Mark Kiel, MD, PhD
Co-founder, Chief Science Officer, Genomenon
Mark Kiel completed his MD Ph.D. and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he supervises the scientific direction of the Mastermind suite of software tools.
|
